First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Competitors GBX 1,501.40 +0.90 (+0.06%) As of 08/12/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock FBT vs. TRST, PRSM, KAPE, KNOS, LTG, ALFA, GBG, IMO, NCC, and CERShould you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include Trustpilot Group (TRST), Blue Prism Group (PRSM), Kape Technologies (KAPE), Kainos Group (KNOS), Learning Technologies Group (LTG), Alfa Financial Software (ALFA), GB Group (GBG), IMImobile (IMO), NCC Group (NCC), and Cerillion (CER). These companies are all part of the "software - application" industry. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation vs. Its Competitors Trustpilot Group Blue Prism Group Kape Technologies Kainos Group Learning Technologies Group Alfa Financial Software GB Group IMImobile NCC Group Cerillion First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) and Trustpilot Group (LON:TRST) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, institutional ownership, risk and profitability. Which has stronger earnings and valuation, FBT or TRST? Trustpilot Group has higher revenue and earnings than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Trustpilot Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AN/AN/A-£1.10-1,364.91Trustpilot Group£222.55M5.27£20.08M£3.0274.12 Is FBT or TRST more profitable? Trustpilot Group has a net margin of 9.02% compared to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's net margin of 0.00%. Trustpilot Group's return on equity of 29.53% beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's return on equity.Company Net Margins Return on Equity Return on Assets First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/A N/A N/A Trustpilot Group 9.02%29.53%1.45% Does the media refer more to FBT or TRST? In the previous week, Trustpilot Group had 2 more articles in the media than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. MarketBeat recorded 2 mentions for Trustpilot Group and 0 mentions for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. Trustpilot Group's average media sentiment score of 0.30 beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's score of 0.00 indicating that Trustpilot Group is being referred to more favorably in the news media. Company Overall Sentiment First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Neutral Trustpilot Group Neutral Do institutionals and insiders believe in FBT or TRST? 78.2% of Trustpilot Group shares are owned by institutional investors. 8.2% of Trustpilot Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts recommend FBT or TRST? Trustpilot Group has a consensus target price of GBX 310, indicating a potential upside of 38.64%. Given Trustpilot Group's stronger consensus rating and higher possible upside, analysts plainly believe Trustpilot Group is more favorable than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Trustpilot Group 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryTrustpilot Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 13 of the 13 factors compared between the two stocks. Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBT vs. The Competition Export to ExcelMetricFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationSoftware IndustryComputer SectorLON ExchangeMarket Cap£615.90M£6.46B£29.77B£3.10BDividend YieldN/A3.24%3.11%5.03%P/E Ratio-1,364.9129.0152.13172.05Price / SalesN/A269.671,371.46290,051.99Price / Cash3.5417.1635.5327.94Price / BookN/A10.689.295.17Net IncomeN/A£49.83M£803.11M£5.89B7 Day Performance-1.60%-1.45%1.55%0.30%1 Month Performance-0.88%-1.93%1.40%3.64%1 Year Performance-5.00%8.34%24,023.86%59.65% First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBTFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AGBX 1,501.40+0.1%N/A-4.1%£615.90MN/A-1,364.9120High Trading VolumeTRSTTrustpilot Group1.5685 of 5 starsGBX 245.68+0.8%GBX 310+26.2%+18.6%£1.29B£222.55M81.44820News CoveragePRSMBlue Prism GroupN/AN/AN/AN/A£1.24B£167.30M-23.681,025High Trading VolumeKAPEKape TechnologiesN/AN/AN/AN/A£1.22B£623.48M1,900.00850Gap DownKNOSKainos Group3.458 of 5 starsGBX 709+0.9%GBX 1,070+50.9%-34.3%£895.54M£383.18M18.582,953News CoverageLTGLearning Technologies Group3.5165 of 5 starsN/AGBX 90+∞N/A£792.10M£529.20M16.755,001ALFAAlfa Financial Software1.4216 of 5 starsGBX 231.50+0.2%GBX 270+16.6%+17.5%£693.30M£103.11M31.29475Gap UpGBGGB Group2.3594 of 5 starsGBX 225+0.2%GBX 390+73.3%-33.8%£567.51M£276.95M-11.681,183Gap UpIMOIMImobileN/AN/AN/AN/A£490.40M£164.04M123.755,300NCCNCC Group1.589 of 5 starsGBX 144.40-0.1%GBX 175+21.2%-6.2%£455.26M£326.70M-18.192,200Dividend CutCERCerillionN/AGBX 1,510+0.3%GBX 2,350+55.6%-17.8%£447.80M£41.39M31.83321Dividend Increase Related Companies and Tools Related Companies Trustpilot Group Competitors Blue Prism Group Competitors Kape Technologies Competitors Kainos Group Competitors Learning Technologies Group Competitors Alfa Financial Software Competitors GB Group Competitors IMImobile Competitors NCC Group Competitors Cerillion Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:FBT) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access